Search results
Novavax stock skyrockets 120% on $1.2 billion vaccine deal with Sanofi
Quartz· 5 days agoUnder the terms of the agreement, Sanofi will begin to book sales of Novavax’s COVID-19 vaccine...
Novavax shares soar on license deal with Sanofi at lofty valuation
Reuters· 3 days ago, opens new tab for its COVID-19 vaccine in exchange for a stake that valued the U.S. biotech firm...
2 Healthcare Stocks to Buy and Hold for Great Long-Term Potential
The Motley Fool via AOL· 1 day agoThe drug maker experienced a massive surge in sales and earnings during the COVID-19 pandemic's...
Adult RSV Shots Given to More Than 30 Babies by Mistake
MedPage Today· 7 days agoData from the Vaccine Adverse Event Reporting System (VAERS) revealed 27 reports of the Pfizer RSV ...
Expert reaction: AstraZeneca withdraws its COVID-19 vaccine
Cosmos· 5 days agoAstraZeneca developed the first vaccine for COVID-19, beating the competition, but this week they’ve...
Pfizer whistleblower shares chilling video: ‘Tired of feeling like I have no hope…but I am NOT...
BizPac Review· 6 days agoA woman has come forward claiming to be a Pfizer whistleblower with a helluva story to tell about the pharmaceutical giant. In addition, she’s published an ominous video declaring ...
Novavax stock soars 40% on Sanofi partnership
Investing.com· 6 days agoThe company's revenue was $93.85 million, significantly falling short of the consensus estimate of $141.16 million. Despite missing Q1 estimates, NVAX...
3 Profitable Dividend Stocks to Buy at Near-Lows
InvestorPlace via Yahoo Finance· 6 days agoUndervalued dividend stocks present two return routes: price appreciation or dividend payments that add to income. As of this writing, the market has...
UPDATE 3-Novavax signs COVID-19 license deal with Sanofi, revokes 'going concern' warning
Reuters via Yahoo Finance· 5 days agoNovavax on Friday removed doubts about its ability to remain in business and struck a licensing deal worth up to $1.2 billion with Sanofi for COVID-19 vaccines< ...
3 No-Brainer Stocks to Buy With $500 Right Now
Motley Fool via Yahoo Finance· 9 hours agoOver the last two years, one of Wall Street's largest drug developers became a victim of its own success. During the COVID-19 pandemic, Pfizer was one of...
